Biologic imaging reagents refer to substances used by researchers or medical practitioners to conduct diagnostic or research based exercises. Biologic imaging reagents play a pivotal role in the field of healthcare and other life science industries. They provide significant assistance in the detection of biological processes at a molecular level. Moreover, these imaging reagents assist medical practitioners and physicians in obtaining diagnostic information for the detection and treatment of diseases especially in the field of cardiovascular, oncology and neurology.
The high prevalence of cardiovascular diseases, neurological diseases and cancer is the most important driving factor for this market. According to WHO, cardiovascular diseases is one of leading causes of death. This coupled with the rising patient awareness levels will drive the growth of this market by causing a rise in the number of diagnostic procedures. Moreover, growing demand for diagnostic imaging devices such as MRI and x-ray devices induced by the introduction of digital and portable systems and the implementation of PACS (picture archiving and communication systems) will cause a surge in the demand for biologic imaging reagents.
The contrast reagents market is further segmented into MRI reagents, ultrasound reagents and x-ray and CT reagents. This market is expected to lead the overall market in terms of share throughout the forecast period. High volume of diagnostic procedures performed using x-ray devices, ultrasound and MRI and rising popularity of these devices on account of growing demand for point of care diagnostics and home healthcare markets attribute to the aforementioned fact.
The radiopharmaceuticals market holds immense growth opportunities and its market is expected to exhibit a double digit growth rate during the forecast period. Growing research and development initiatives and increasing awareness levels pertaining to nuclear medicine accounts for this high growth rate.
Request for TOC of this report at:
North America dominates the market in terms of share owing to the presence of sophisticated healthcare infrastructure, high per capita healthcare expenditure and patient awareness levels. However, the Asia-Pacific biologic imaging reagents market will grow at the highest rate during the forecast period. The presence of high unmet medical needs and growing economic growth supporting healthcare infrastructure improvement in countries such as India and China attributes to this fact.
This research study encompasses a competitive landscape of the biologic imaging reagents market. Revenue analysis, product benchmarking and strategic developments of key market players such as Bayer Healthcare AG, Beckman Coulter Inc., Bracco Imaging, Cardinal Health, Johnson and Johnson, Philips Healthcare, Siemens Healthcare and others are also provided in this report.
Grand View’s market research study takes a closer look at the biologic imaging reagents industry, providing a holistic perspective on market dynamics, patient preference and disease trends, supply and demand. Our report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro environmental level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including contrast reagents, radiopharmaceuticals and optical imaging reagents. The report analyzes the market for all the aforementioned product segments on a regional basis. Major geographies accounted for in this research study include North America, Europe and Asia-Pacific.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment